For weight management, the Food and Drug Administration (FDA) has approved two medications: Semaglutide (Wegovy) Tirzepatide (Zepbound) These drugs contain the same active ingredients as diabetes medications such as Ozempic and Mounjaro, but Wegovy and Zepbound are specifically approved for chronic weight management
Insurance Does not accept insurance HSA/FSA eligible (accepts FSA and HSA cards directly) No insurance concierge or prior authorization support Cash-pay only, major credit cards accepted Cancellation & Refund Policy This is where SkinnyRx loses points
Researchers and analysts have attributed this sustained trajectory to the glucagon receptor component of retatrutides mechanism
GLP-1 improves adipocyte insulin sensitivity following induction of endoplasmic reticulum stress
Additionally, intraperitoneal administration of GLP-1 at supraphysiological doses elicited an anti-adipogenic effect in rats (72), making GLP-1 a potential target for obesity treatment
Theyre now required to stop producing compounded versions within a few months
